Management of Hypertension and Dyslipidaemia in Patients Presenting with Hyperuricaemia: Case Histories
- 1 January 2000
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 16 (3) , 164-170
- https://doi.org/10.1185/0300799009117021
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Treatment of Dyslipidaemias in Patients with Established Vascular Disease: A Revival of the FibratesCurrent Medical Research and Opinion, 2000
- Safety of losartan in hypertensive patients with thiazide-induced hyperuricemiaKidney International, 1999
- Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?International Journal of Cardiology, 1999
- Platelet function and lipid-lowering interventionsPlatelets, 1999
- Hyperlipidaemia, hypertension, and coronary heart diseaseThe Lancet, 1995
- Acute Flank Pain and Hematuria: Lessons from Adverse Drug Reaction ReportingThe Journal of Clinical Pharmacology, 1988
- Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham StudyAmerican Heart Journal, 1987
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences, 1981
- Atherosclerosis and Urate MetabolismAustralian and New Zealand Journal of Medicine, 1979
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963